Meridigen Biotech Co., Ltd.
🇨🇳China
Mesenchymal Stem Cells for The Treatment of Frailty Syndrome
Phase 1
Recruiting
- Conditions
- Frailty Syndrome
- Interventions
- Biological: UMC119-06-05
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Meridigen Biotech Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT04914403
- Locations
- 🇨🇳
Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan
Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).
Phase 1
Recruiting
- Conditions
- Osteoarthritis, Knee
- Interventions
- Biological: UMC119-06-05Device: Hyaluronic acid
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Meridigen Biotech Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT04893174
- Locations
- 🇨🇳
Taipei Medical University Hospital, Taipei, Taiwan
Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)
Phase 1
Not yet recruiting
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- Biological: UMC119-06
- First Posted Date
- 2020-04-15
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Meridigen Biotech Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT04347967
- Locations
- 🇨🇳
Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan
Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease
Phase 1
Active, not recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease Moderate
- Interventions
- Biological: UMC119-06
- First Posted Date
- 2019-12-20
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Meridigen Biotech Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT04206007
- Locations
- 🇨🇳
Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan
Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke
Phase 1
Recruiting
- Conditions
- Acute Ischemic Stroke
- Interventions
- Biological: UMC119-06
- First Posted Date
- 2019-09-20
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Meridigen Biotech Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT04097652
- Locations
- 🇨🇳
Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
Phase 1
Recruiting
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Biological: Human Umbilical Cord Derived-Mesenchymal Stem Cells
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Meridigen Biotech Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT03631420
- Locations
- 🇨🇳
National Chen-Kung University Hospital, Tainan City, Taiwan
© Copyright 2025. All Rights Reserved by MedPath